Skip to main content
. Author manuscript; available in PMC: 2012 May 2.
Published in final edited form as: Ann Emerg Med. 2011 Jan 12;57(5):475–82.e1. doi: 10.1016/j.annemergmed.2010.11.023

Table 2.

Secondary outcomes

Metoclopramide 10mg Metoclopramide 20mg Metoclopramide 40mg
Wish to receive this medication the next ER visit 77/104 *
74% (65, 81%)		 83/108*
77% (68, 84%)		 80/104*
77% (68, 84%)
2 hour headache relief 93/113
82% (74, 88%)		 94/117*
80% (72, 86%)		 100/117*
86% (79, 91%)
2 hour headache freedom 49/113
43% (34, 52%)		 53/117*
45% (36, 54%)		 51/117*
44% (35, 53%)
2 hour normal functional status 70/112*
63% (54, 71%)		 68/117*
58% (49, 67%)		 80/115*
70% (61, 78%)
Sustained relief 58/107*
54% (45, 63%)		 63/116*
54% (45, 63%)		 69/106*
65% (56, 73%)
Sustained pain free 18/111*
16% (10, 24%)		 23/116*
20% (14, 28%)		 24/113*
21% (15, 29%)
Time to discharge, minutes (median [IQR]) 160 (108, 275) 154 (97, 226) 158 (114, 254)
Requested rescue medication one hour later 23/113*
20% (14, 28%)		 18/116*
16 % (10, 24%)		 21/114*
18% (12, 26%)

Reported as percent and 95%CI unless otherwise noted

*

Some secondary outcome data is missing either because patients were lost-to-follow-up or because they refused/couldn’t answer the question